BCL2 and leukemia: Consistently, we describe how forskolin in combinatorial treatments markedly enhances the toxicity of the epigenetic agent GSKJ4 in leukemia cells, inducing apoptotic cell death paralleled by a strong reduction of BCL-2 protein levels, via a mechanism dependent on PKA activity.